MedPath

IS-10506

Generic Name
IS-10506

Efficacy and Safety of Probiotics in Neonatal Hyperbilirubinemia

Phase 3
Conditions
Hyperbilirubinemia, Neonatal
Interventions
First Posted Date
2017-08-30
Last Posted Date
2017-08-30
Lead Sponsor
Hormozgan University of Medical Sciences
Target Recruit Count
126
Registration Number
NCT03266913
Locations
🇮🇷

Children hospital, Bandar Abbas, Hormozgan, Iran, Islamic Republic of

Effect of Probiotic Lactobacillus Reuteri in the Treatment of Mucositis and Periimplantitis

Phase 4
Completed
Conditions
Mucositis
Peri-implantitis
Interventions
Device: Placebo Oral Tablet
First Posted Date
2017-02-08
Last Posted Date
2020-03-30
Lead Sponsor
Universitat Internacional de Catalunya
Target Recruit Count
44
Registration Number
NCT03047291

The Effect of Probiotics on Microbial Translocation and Inflammation in HIV-infected Patients

Not Applicable
Completed
Conditions
HIV
Interventions
First Posted Date
2016-05-06
Last Posted Date
2016-10-11
Lead Sponsor
Rigshospitalet, Denmark
Target Recruit Count
45
Registration Number
NCT02764684
Locations
🇩🇰

Rigshospitalet, Copenhagen, Denmark

Pregnancy Complications - A Probiotic Interventional Study

Not Applicable
Completed
Conditions
Preeclampsia
Preterm Birth
Interventions
Drug: placebo
First Posted Date
2016-02-26
Last Posted Date
2022-06-03
Lead Sponsor
Sahlgrenska University Hospital, Sweden
Target Recruit Count
105
Registration Number
NCT02693041
Locations
🇸🇪

Bo Jacobsson, Gothenburg, Sweden

Effect of Probiotics on GBS Colonization Status During Pregnancy: A Pilot Randomized Controlled Trial

Not Applicable
Completed
Conditions
Group B Streptococcal Infection
Interventions
Drug: Placebo
First Posted Date
2015-08-19
Last Posted Date
2017-03-07
Lead Sponsor
Toronto Metropolitan University
Target Recruit Count
114
Registration Number
NCT02528981
Locations
🇨🇦

Ryerson University, Toronto, Ontario, Canada

Evaluation of the Efficacy of Probiotics in Chronic Periodontitis Patients

Phase 3
Completed
Conditions
Chronic Periodontitis
Interventions
Drug: Placebo
First Posted Date
2015-03-17
Last Posted Date
2017-01-10
Lead Sponsor
Next Gen Pharma India Pvt. Ltd.
Target Recruit Count
31
Registration Number
NCT02390687
Locations
🇮🇳

Department of Periodontics, K.V.G. College & Hospital,, Kurunjibhag, Sullia (D.K.), Karnataka, India

Intestinal Microflora in Colorectal Cancer (CRC) After Chemotherapy

Phase 1
Conditions
Gastrointestinal Neoplasms
Colorectal Cancer
Effects of Chemotherapy
Tumor Immunity
Malnutrition
Interventions
Drug: placebo(for probiotic)
First Posted Date
2014-06-23
Last Posted Date
2014-06-25
Lead Sponsor
Shandong University
Target Recruit Count
30
Registration Number
NCT02169388
Locations
🇨🇳

Department of Gastroenterology,Qilu Hospital,Shandong University, Jinan, Shandong, China

Can Probiotics be Used in the Prevention of Recurrent UTI in Paediatric Neurogenic Bladder

Phase 1
Conditions
Urinary Tract Infection
Interventions
Other: Antibiotic
First Posted Date
2014-01-24
Last Posted Date
2021-09-09
Lead Sponsor
London Health Sciences Centre
Target Recruit Count
36
Registration Number
NCT02044965
Locations
🇨🇦

London Health Sciences Centre, London, Ontario, Canada

Probiotics in the Treatment of Irritable Bowel Syndrome

Phase 2
Completed
Conditions
Irritable Bowel Syndrome
Interventions
Drug: Placebo
First Posted Date
2013-04-23
Last Posted Date
2013-04-23
Lead Sponsor
Isfahan University of Medical Sciences
Target Recruit Count
132
Registration Number
NCT01837472
Locations
🇮🇷

Department of Gastroenterology, Alzahra Hospital, Isfahan, Iran, Islamic Republic of

The Effect of Probiotics on Exacerbation of Inflammatory Bowel Disease Exacerbation (Crohn's Disease)

Phase 4
Conditions
Crohn's Disease
Interventions
Drug: Placebo
First Posted Date
2013-01-11
Last Posted Date
2013-01-11
Lead Sponsor
The Baruch Padeh Medical Center, Poriya
Target Recruit Count
60
Registration Number
NCT01765998
Locations
🇮🇱

Baruch Padeh Medical Center, Tiberias, Lower galilee, Israel

© Copyright 2025. All Rights Reserved by MedPath